Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US9856287 | AMGEN, INC. | Refolding proteins using a chemically controlled redox state |
Jun, 2030
(6 years from now) |
Ingredients: PEGFILGRASTIM
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic